📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Isobionics

1.1 - Company Overview

Isobionics Logo

Isobionics

Headquarter: The Netherlands
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of isoprenoid-based flavor and fragrance ingredients produced via a proprietary biotechnology process for the food, beverage, flavor and fragrance markets, delivering higher quality and purity at lower production cost. Portfolio includes Natural Nootkatone, beta-Caryophyllene, Valencene, (-)-alpha-Bisabolol, alpha-Bisabolene, and beta-Bisabolene.

Products and services

  • Isobionics Natural Nootkatone 98: Biotechnology-produced ingredient (98% purity) delivering clean, fruity grapefruit odor with grapefruit juice and cedar incense taste for food, beverage, flavor, and fragrance applications
  • Isobionics Natural Valencene 80: Isoprenoid-based ingredient (80% purity) featuring pithy subdued orange juice note and waxy, orange pith, warm olibanum, woody odor for flavor and fragrance uses
  • Isobionics Natural beta-Caryophyllene 80: Biotechnology-derived ingredient (80% purity) with herbaceous, slightly green, oily, woody grapefruit/citrus odor and woody, herbal, fatty grapefruit taste for food, beverage, flavor applications

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Isobionics

Seraxis Logo

Seraxis

HQ: United States Website
  • Description: Provider of cell replacement therapy and lab-grown pancreatic islets for insulin-dependent diabetes. Offerings include SR-01, which combines lab-grown human islets with a technology to implant these islets without immune suppression; SR1423, a stem cell line maturing into insulin-secreting islets; and lab-grown islets that mimic native pancreatic function and respond to glucose.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Seraxis company profile →
Mabtech Logo

Mabtech

HQ: Sweden Website
  • Description: Provider of monoclonal antibodies and immunoassay kits for ELISA, ELISpot, and FluoroSpot; automated readers (Mabtech IRIS 2 for ELISpot, FluoroSpot, and FociSpot; Mabtech ASTOR 2 for ELISpot) for spot counting and data analysis; and reagents including peptide pools, polyclonal stimuli, buffers, substrates, plates, and antibodies to cytokines, immunoglobulins, and apolipoproteins.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Mabtech company profile →
Afyren Logo

Afyren

HQ: France Website
  • Description: Provider of biotechnological and green chemistry solutions that valorize non-food biomass into biosourced molecules and natural organic acids. Offers AFYREN NEOXY production facility, FLAVYREN flavor and fragrance acids with a low carbon footprint, and a circular eco approach using organic waste and aiming for zero industrial waste via by-product valorization.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Afyren company profile →
List Labs Logo

List Labs

HQ: United States Website
  • Description: Provider of microbial CDMO services, offering end-to-end support from early-stage process development to cGMP manufacturing for Phase I & II clinical supply, and research reagents including nearly 100 bacterial toxins, polysaccharides, and antibodies. Also supplies anthrax (PA, EF, LF), botulinum, C. difficile (Toxin A/B), and cholera toxins, and specializes in native toxins, recombinant proteins, fermentation, and assay development.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full List Labs company profile →
Newomics Logo

Newomics

HQ: United States Website
  • Description: Provider of integrative platforms for personalized healthcare, offering mass spectrometry and LC-MS solutions including DuoESI Source (dual ion source enhancing ionization for multiomics, compatible with leading mass spectrometers), MEA Chip (silicon LC column/ESI emitter/post-column inlet chip for improved sensitivity and robustness in proteomics), and M3 Emitter (silicon microfluidic flow-splitting emitter for enhanced ionization).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Newomics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Isobionics

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Isobionics

2.2 - Growth funds investing in similar companies to Isobionics

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Isobionics

4.2 - Public trading comparable groups for Isobionics

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Isobionics

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Isobionics

What does Isobionics do?

Isobionics is a provider of isoprenoid-based flavor and fragrance ingredients produced via a proprietary biotechnology process for the food, beverage, flavor and fragrance markets, delivering higher quality and purity at lower production cost. Portfolio includes Natural Nootkatone, beta-Caryophyllene, Valencene, (-)-alpha-Bisabolol, alpha-Bisabolene, and beta-Bisabolene.

Who are Isobionics's competitors?

Isobionics's competitors and similar companies include Seraxis, Mabtech, Afyren, List Labs, and Newomics.

Where is Isobionics headquartered?

Isobionics is headquartered in The Netherlands.

How many employees does Isobionics have?

Isobionics has 1,000 employees 🔒.

When was Isobionics founded?

Isobionics was founded in 2010 🔒.

What sector and industry vertical is Isobionics in?

Isobionics is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Isobionics

Who are the top strategic acquirers in Isobionics's sector and industry

Top strategic M&A buyers and acquirers in Isobionics's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Isobionics?

Top strategic M&A buyers groups and sectors for Isobionics include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Isobionics's sector and industry vertical

Which are the top PE firms investing in Isobionics's sector and industry vertical?

Top PE firms investing in Isobionics's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Isobionics's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Isobionics's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Isobionics's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Isobionics include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Isobionics's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Isobionics?

The key public trading comparables and valuation benchmarks for Isobionics include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Isobionics for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Isobionics with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Isobionics's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Isobionics with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Isobionics's' sector and industry vertical?

Access recent funding rounds and capital raises in Isobionics's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Isobionics